ARCHIVES

FDA Authority To Remove Paclitaxel Patent Questioned.

This article is from The Cancer Letter archive.

Vol. 27 No. 06 | February 9, 2001

Download PDF Visit The Full Archive

Related Articles

New Jersey Legislature Votes to Oppose USPSTF PSA Screening Downgrade

January 20, 2012

Flood Asks ACCC for Greater Community Effort

February 14, 1975

Liver Transplant Associated With 67% 5-Year Survival

February 23, 2007

NKTR-102 Shows 29 Percent Response in Phase II Study

September 30, 2011

NCAB Seeks Exemption From New Reimbursement Plan For Clinical Trials, Modification Of Hospice Regs

February 11, 1983

NIH Consensus Panel Calls for Large Randomized Trials of Hepatitis B Therapies.

October 31, 2008